Survival benefit of surgery after chemoradiotherapy for stage III (N0-2) non-small-cell lung cancer is dependent on pathologic nodal response

Journal of Thoracic Oncology

Volumn 10, Issue 10, 2015, Pages 1475-1480

  Ziel, Ellis ^a   Hermann, Gregory ^b   Sen, Neilayan ^c   Bonomi, Philip ^c   Liptay, Michael J ^c   Fidler, Mary Jo ^c   Batus, Marta ^c   Warren, William H ^c   Chmielewski, Gary ^c   Sher, David J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemoradiotherapy; Mediastinal staging; Non small cell lung cancer; Trimodality therapy

Indexed keywords

CARBOPLATIN; PACLITAXEL; PEMETREXED;

AGED; ARTICLE; ATRIAL FIBRILLATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; EMPYEMA; FEMALE; FOLLOW UP; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HEART INFARCTION; HUMAN; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; SURGICAL PATIENT; TREATMENT RESPONSE; ADJUVANT CHEMORADIOTHERAPY; CARCINOMA, NON-SMALL-CELL LUNG; COHORT ANALYSIS; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; PATHOLOGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84942515859     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000639     Document Type: Article

References (19)

1. Curran WJ, Sause W, Langer CJ, et al. Sequential vs concurrent chemora-diation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011; 103: 1452-1460.
2. Ettinger DS, Akerley W, Borghaei H, et al.; NCCN (National Comprehensive Cancer Network). Non-small cell lung cancer. J Natl Compr Canc Netw 2012;10:1236-1271.
3. Albain KS, Swann RS, Rusch V W, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379-386.
4. Sher DJ, Liptay MJ, Fidler MJ. Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution. Int J Radiat Oncol Biol Phys 2014;89:303-312.
5. Albain KS, Rusch V W, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880-1892.
6. Lee H, Ahn YC, Pyo H, et al. Pretreatment clinical mediastinal nodal bulk and extent do not infuence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy. Ann Surg Oncol 2014;21:2083-2090.
7. Kim AW, Liptay MJ, Bonomi P, et al. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients. Ann Thorac Surg 2011;92:233-241; discussion 241.
8. Machtay M, Lee JH, Stevenson J P, et al. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thorac Cardiovasc Surg 2004;127:108-113.
9. Betticher DC, Hsu Schmitz S F, Tötsch M, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003;21:1752-1759.
10. Trodella L, Granone P, Valente S, et al. Neoadjuvant concurrent radio-chemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. Ann Oncol 2004;15:389-398.
11. Gielda BT, Marsh JC, Zusag T W, et al. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol 2011;6:1079-1086.
12. van Meerbeeck J P, Kramer G W, Van Schil PE, et al.; European Organisation for Research and Treatment of Cancer-Lung Cancer Group. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007;99:442-450.
13. Thomas M, Rübe C, Hoffknecht P, et al.; German Lung Cancer Cooperative Group. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 2008;9:636-648.
14. Cerfolio RJ, Bryant AS, Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg 2006;131:1229-1235.
15. De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for pre-operative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;45:787-798.
16. Stamatis G, Fechner S, Hillejan L, Hinterthaner M, Krbek T. Repeat medi-astinoscopy as a restaging procedure. Pneumologie 2005;59:862-866.
17. Jaklitsch MT, Herndon JE 2nd, DeCamp MM Jr, et al. Nodal downstag-ing predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. J Surg Oncol 2006;94:599-606.
18. Inoue M, Sawabata N, Takeda S, Ohta M, Ohno Y, Maeda H. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 2004;127:1100-1106.
19. Cerfolio RJ, Bryant AS. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Ann Thorac Surg 2008;86:362-366; discussion 366.